Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.1M Sell
11,596
-177
-2% -$282K 1.63% 15
2026
Q1
$15.6M Sell
11,773
-1,001
-8% -$1.37M 1.24% 21
2025
Q4
$13.7M Sell
12,774
-3,515
-22% -$3.67M 1.03% 29
2025
Q3
$15.8M Buy
16,289
+224
+1% +$176K 1.15% 23
2025
Q2
$12.9M Buy
16,065
+198
+1% +$142K 1% 32
2025
Q1
$10.5M Buy
15,867
+5,610
+55% +$4.08M 0.89% 40
2024
Q4
$7.11M Buy
+10,257
New +$7.37M 0.59% 48

Other funds holding ASML

Nixon Peabody Trust's ASML Position: Q2 2026 in Review

Nixon Peabody Trust reduced its ASML (ASML) stake by 1.5% in Q2 2026, selling an estimated $282K and leaving 11,596 shares worth $23.1M. The position accounts for 1.63% of the portfolio, ranked #15.

Nixon Peabody Trust first reported a position in ASML in Q4 2024 and has held it in 7 quarters since. 924 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Nixon Peabody Trust held 11,596 shares of ASML worth $23.1M as of Q2 2026.
  • Nixon Peabody Trust sold 177 ASML shares in Q2 2026, an estimated $282K.
  • ASML made up 1.63% of Nixon Peabody Trust's portfolio in Q2 2026, its #15 holding.
  • Nixon Peabody Trust first reported a position in ASML in Q4 2024 and has held it in 7 quarters since.
  • 924 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Nixon Peabody Trust's 13F filing for Q2 2026, filed 27 Jul 2026.